5 Dividend Stocks in Warren Buffett’s Latest Portfolio

4. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders: 82  

Forward Dividend Yield: 4.81%

AbbVie Inc. (NYSE:ABBV) develops and markets pharmaceutical products. Berkshire Hathaway owned 14 million shares in the company at the end of September 2021 worth $1.5 billion, representing 0.52% of the portfolio of the fund. 

Morgan Stanley analyst David Risinger has an Overweight rating on AbbVie Inc. (NYSE:ABBV) stock with a price target of $124. In an investor note penned in early November, the analyst appreciated the strong quarterly earnings of the pharma firm. 

At the end of the second quarter of 2021, 82 hedge funds in the database of Insider Monkey held stakes worth $5.3 billion in AbbVie Inc. (NYSE:ABBV), up from 72 in the preceding quarter worth $5.9 billion.